NASDAQ Gives CNS Pharmaceuticals a Second Chance: Minimum Bid Price Requirement No Longer a Headache!
Breaking News: CNS Pharmaceuticals Granted Exception by Nasdaq Hearings Panel November 1, 2024 Exciting news for CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)! The biopharmaceutical company, known for its focus on developing innovative treatments for cancers in the brain and central nervous system, has just announced that it has been granted an exception by The Nasdaq Hearings Panel….